Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Conrad F. Mir currently holds 1,440,751 shares of CALMARE THERAPEUTICS Inc (CTTC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Conrad F. Mir has been a net neutral trader of CTTC stock. They have purchased $0 and sold $0 worth of shares.
Conrad F. Mir's most recent insider trade was on Feb 12, 2018, when they sold 1,000,000 shares at $0.08 per share.
Conrad F. Mir serves as Executive at CALMARE THERAPEUTICS Inc (CTTC). They have executed 1 insider transactions totaling $0 over their tenure at the company.
Conrad F. Mir holds the position of Executive at CALMARE THERAPEUTICS Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Conrad F. Mir has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Conrad F. Mir was on Feb 12, 2018, when they sold $80.0K worth of CTTC shares. This transaction involved 1,000,000 shares at $0.08 per share.
Conrad F. Mir currently owns 1,440,751 shares of CALMARE THERAPEUTICS Inc (CTTC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Conrad F. Mir's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Conrad F. Mir has 1 Form 4 filings on record as an insider at CALMARE THERAPEUTICS Inc.
Set alerts for Conrad F. Mir and 40,000+ other insiders.